HOME OUR COMPANY TECHNOLOGY & INNOVATION R&D PORTFOLIO INVESTORS PARTNERSHIPS NEWS & EVENTS CAREERS CONTACT Sitemap Ablynx >Sitemap Home Our Company Overview Strategy Management Board of Directors Technology & innovation Understanding Nanobodies Nanobodies Competitive Features Intellectual Property Publications Alternative Routes of Administration Bi-specific and Multivalent Formats / Formatting Cavity Binding Production Features General High Affinity High Selectivity High Solubility and no Tendency to Aggregate Low Toxicity / Immunogenicity Stability Tailored in vivo half-life Tissue Penetration R&D portfolio Overview Clinical Programmes Caplacizumab Vobarilizumab ALX-0171 ALX-0761/M1095 Ozoralizumab ALX-0141 Clinical Trials Patients Investigator Patient Resources Pre-approval Access to IMPs Investors Sanofi acquires Ablynx Corporate Governance Principles, codes and guidelines Partnerships Overview Current Partnerships Contact News & events Overview Press Releases Subscribe Unsubscribe Events & Presentations Image Gallery Careers Working at Ablynx Job Opportunities Contact Contact Form Sitemap Disclaimer Search 2015 - 2018 © Ablynx Disclaimer Sitemap Our Company Technology & innovation R&D portfolio Investors Partnerships News & events Careers Contact

HOME OUR COMPANY TECHNOLOGY & INNOVATION R&D PORTFOLIO INVESTORS PARTNERSHIPS NEWS & EVENTS CAREERS CONTACT Contact Ablynx >Contact CORPORATE Ablynx NV Technologiepark 21 9052 Ghent/Zwijnaarde Belgium Tel: +32 (0)9 262 00 00 Fax: +32 (0)9 262 00 01 info@ablynx.com Fill in the contact form here Ablynx, Inc. Six Tower Bridge, Suite 400 181 Washington Street Conshohocken, PA 19428 USA BUSINESS DEVELOPMENT Business Development bd@ablynx.com PATIENTS It is best to contact your physician regarding participation in any clinical trial. Your physician will be able to determine which clinical trials are running, where they are located, your eligibility to participate and whether participating in a trial would be right for you. clinicaltrials@ablynx.com CLINICAL TRIAL INVESTIGATORS Ablynx's Clinical Research & Development team would like to encourage potential investigators interested in collaborating with Ablynx to register their information on our website via this online form. Please note that registration does not guarantee participation. INVESTOR RELATIONS Sanofi Investor Relations France +33 (0)1 53 77 45 45, United States +1 908 981 5560, ir@sanofi.com CAREERS To explore the current job openings or to apply spontaneously: please register online 2015 - 2018 © Ablynx Disclaimer Sitemap Our Company Technology & innovation R&D portfolio Investors Partnerships News & events Careers Contact